Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |